KUSH PARMAR Insider Trading $FIXX Homology Medicines, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KUSH PARMAR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KUSH PARMAR. KUSH PARMAR is Director in scPharmaceuticals Inc. ($SCPH) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in ARVINAS, INC. ($ARVN) and Director in Homology Medicines, Inc. ($FIXX) and Director in Akouos, Inc. ($AKUS) and Director in Vor Biopharma Inc. ($VOR) and Co-CEO in 5:01 Acquisition Corp. ($FVAM).
KUSH PARMAR in Homology Medicines, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KUSH PARMAR: Director
Holdings: 4,354,484 shares
Latest Transaction: Dec 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KUSH PARMAR in Homology Medicines, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FVAM, AKUS, ARVN, BOLD, FIXX, SCPH, VOR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 12.82 | 20,000 | 256,400 | 181,435 | 201.4 K to 181.4 K (-9.93 %) |
| Dec 28 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 12.82 | 480,000 | 6,153,600 | 4,354,484 | 4.8 M to 4.4 M (-9.93 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 11.88 | 13,703 | 162,792 | 201,435 | 215.1 K to 201.4 K (-6.37 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 13.06 | 6,297 | 82,244 | 215,138 | 221.4 K to 215.1 K (-2.84 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 11.88 | 328,862 | 3,906,881 | 4,834,484 | 5.2 M to 4.8 M (-6.37 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 13.06 | 151,138 | 1,973,998 | 5,163,346 | 5.3 M to 5.2 M (-2.84 %) |
| Jun 12 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Jun 10 2019 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| May 20 2019 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 21.47 | 24,600 | 528,162 | 221,435 | 246 K to 221.4 K (-10.00 %) |
| May 20 2019 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 21.47 | 590,400 | 12,675,888 | 5,314,484 | 5.9 M to 5.3 M (-10.00 %) |
| Dec 12 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 26.01 | 623 | 16,201 | 246,035 | 246.7 K to 246 K (-0.25 %) |
| Dec 12 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 26.01 | 14,952 | 388,828 | 5,904,884 | 5.9 M to 5.9 M (-0.25 %) |
| Nov 27 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 20.04 | 1,187 | 23,783 | 246,658 | 247.8 K to 246.7 K (-0.48 %) |
| Nov 27 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 20.04 | 28,495 | 570,926 | 5,919,836 | 5.9 M to 5.9 M (-0.48 %) |
| Nov 20 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 20.20 | 21,036 | 424,927 | 247,845 | 268.9 K to 247.8 K (-7.82 %) |
| Nov 20 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 20.20 | 504,864 | 10,198,253 | 5,948,331 | 6.5 M to 5.9 M (-7.82 %) |
| Mar 29 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 |
Page: 1